1. Gordon GM. Medical errors: creating the tension for change. Am J Health Syst Pharm.2001;58:908-912.
2.
2. Committee on drugs and committee on hospital care. Pediatrics. 1998;102:428-430.
3.
3. Levine SR, Choen MR, Blanchard NR, et al. Guideline for preventing medication errors in pediatrics. J Pediatr Pharmacol Ther.2001;6:426-442.
4.
4. National Patient Safety Goals-FAQs. http://www.jacho.com/accredited+organizations/patient+safety/npsg/faqsabout+national+.
5.
5. Kohn LT, Corrigan JM, Donaldson MS. To Err Is Human: Building a Safer Health System. 2000; Institute of Medicine, Washington DC, pp. 1-312. http://www.ismp.org/msaarticles/qualitychasm.html.
6.
6. Thompson CA. FDA to develop rules for mandatory bar-code labels. Am J Health-Syst Pharm. 2002;59:107-112.
7.
7. Kaushal R, Barker KN, Bates DW. How can information technology improve patient safety and reduce medication errors in children's health care?Arch Pediatr Adolesc Med. 2001;155:1002-1007.
8.
8. Shane R. Computerized physician order entry: challenges and opportunities. Am J Health-Syst Pharm2002;59:286-288.
9.
9. World Health Organization. International Drug Monitoring: The Role of the Hospital. Geneva, Switzerland: World Health Organization; 1966. Technical Report Series No. 425.
10.
10. Joint Task Force on Practice Parameters. Disease management of drug hypersensitivity: a practice parameter. Ann Allergy Asthma Immunol. 1999:665-700.
11.
11. Holgate ST, Bradding P, Sampson AP. Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy.J Allergy Clin Immunol. 1996;98:1-13.
12.
12. Butler DR, Kuhn RJ, Chandler MHH. Pharmacokinetics of anti-infective agents in paediatric patients. Clin Pharmacokinet. 1994;16:374-395.
13.
13. Leader GW, Chandler MHH, Castiglia M. Pharmacokinetic optimisation of vancomycin therapy. Clin Pharmacokinet. 1995;28:327-342.
15. Duplaga BA. Treatment of childhood hypercholesterolemia with HMG-Ca A reductase inhibitors. Ann Pharmacother1999;33:1224-1227.
16.
16. Horn JR, Hansten PD. Drug interactions with antibacterial agents. J Fam Pract. 1995;41:81-90.
17.
17. Michalets EL. Update: clinically significant cytochrome P-450 drug interactions. Pharmacotherapy. 1998;18:84-112.
18.
18. French JA, Gidal BE. Antiepileptic drug interactionsEpilepsia. 2000;41(suppl 8):S30-S36.
19.
19. Ellis EF. Allergic disorders. Nelson Textbook of Pediatrics, 12th ed.Philadelphia: WB Saunders Co; 2000:689-694.
20.
20. R. Michael Sly. Adverse reaction to drugs. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics, 16th ed.Philadelphia. WB Saunders Co; 2000:689-694.
